Protein A Resins Market Size, Trends & Forecast 2026–2035

Protein A Resins Market - By Product, By Matrix Type, By Application, By End Use - Global Forecast, 2026 - 2035

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary 

2.1&nbsp;&nbsp;&nbsp; Industry 360&ordm; synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Product trends

2.2.3&nbsp;&nbsp;&nbsp; Matrix type trends

2.2.4&nbsp;&nbsp;&nbsp; Application trends

2.2.5&nbsp;&nbsp;&nbsp; End use trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights 

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising demand for vaccine and therapeutic antibodies

3.2.1.2&nbsp;&nbsp;&nbsp; Increasing prevalence of chronic diseases

3.2.1.3&nbsp;&nbsp;&nbsp; Growing drug discovery and research and development activity

3.2.1.4&nbsp;&nbsp;&nbsp; Technology advancements in protein A resins

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Rise in alternative methods for the purification of monoclonal antibodies

3.2.2.2&nbsp;&nbsp;&nbsp; High cost of the matrix resins

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Regional expansion in emerging markets

3.2.3.2&nbsp;&nbsp;&nbsp; Sustainability and cost-effectiveness

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.5.1&nbsp;&nbsp;&nbsp; Current technological trends

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Patent analysis

3.7&nbsp;&nbsp;&nbsp; Future market trends

3.8&nbsp;&nbsp;&nbsp; Pricing analysis

3.9&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2025

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.2.1&nbsp;&nbsp;&nbsp; Global

4.2.2&nbsp;&nbsp;&nbsp; North America

4.2.3&nbsp;&nbsp;&nbsp; Europe

4.2.4&nbsp;&nbsp;&nbsp; Asia Pacific

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Key development

4.6.1&nbsp;&nbsp;&nbsp; Mergers and acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships and collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Natural protein A resin

5.3&nbsp;&nbsp;&nbsp; Recombinant protein A resin

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Matrix Type, 2022 - 2035 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Agarose-based matrix

6.3&nbsp;&nbsp;&nbsp; Glass or silica gel-based matrix

6.4&nbsp;&nbsp;&nbsp; Organic polymer-based matrix

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Immunoprecipitation

7.3&nbsp;&nbsp;&nbsp; Antibody purification

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Pharmaceutical and biopharmaceutical companies

8.3&nbsp;&nbsp;&nbsp; CROs and CDMOs

8.4&nbsp;&nbsp;&nbsp; Academic and research institutes

8.5&nbsp;&nbsp;&nbsp; Other end users

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Italy

9.3.5&nbsp;&nbsp;&nbsp; Spain

9.3.6&nbsp;&nbsp;&nbsp; Netherlands

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; India

9.4.3&nbsp;&nbsp;&nbsp; Japan

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.6&nbsp;&nbsp;&nbsp; Middle East and Africa

9.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.2&nbsp;&nbsp;&nbsp; South Africa

9.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles 

10.1&nbsp;&nbsp;&nbsp; Agarose Beads Technologies

10.2&nbsp;&nbsp;&nbsp; Agilent Technologies

10.3&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories

10.4&nbsp;&nbsp;&nbsp; Danaher Corporation

10.5&nbsp;&nbsp;&nbsp; GenScript

10.6&nbsp;&nbsp;&nbsp; Merck

10.7&nbsp;&nbsp;&nbsp; Purolite

10.8&nbsp;&nbsp;&nbsp; Repligen Corporation

10.9&nbsp;&nbsp;&nbsp; Takara Bio

10.10&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

10.11&nbsp;&nbsp;&nbsp; Tosoh Bioscience

&nbsp;&nbsp;&nbsp;

Protein A Resins Market

Customize This Report